DAVID MOATAZEDI Insider Trading
Get free email notifications about insider trading for DAVID MOATAZEDI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID MOATAZEDI. DAVID MOATAZEDI is a in OBALON THERAPEUTICS INC ($OBLN) and a See Remarks in Evolus, Inc. ($EOLS).
Address: C/O OBALON THERAPEUTICS, INC. 5421 AVENIDA ENCINAS, SUITE F CARLSBAD 92008 CA
Companies in which DAVID MOATAZEDI is an Insider
Evolus, Inc.
Trading Symbol: EOLSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID MOATAZEDI: See Remarks
Holdings: 489,280 shares
Latest Transaction: Mar 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ReShape Lifesciences Inc.
Trading Symbol: OBLNIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of DAVID MOATAZEDI:
Holdings: 83,619 shares
Current Value: $799,398
Latest Transaction: Jul 25 2019
$OBLN Market Capitalization: $158.66M
$OBLN Previous Close: $9.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID MOATAZEDI
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 26 2021 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Grant | A | 0.00 | 48,853 | 0 | 489,280 | 440.4 K to 489.3 K (+11.09 %) |
Feb 01 2021 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Grant | A | 0.00 | 266,667 | 0 | 440,427 | 173.8 K to 440.4 K (+153.47 %) |
Jan 26 2021 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Sell | S | 7.46 | 8,310 | 61,993 | 173,760 | 182.1 K to 173.8 K (-4.56 %) |
May 15 2020 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Grant | A | 0.00 | 100,000 | 0 | 182,070 | 82.1 K to 182.1 K (+121.85 %) |
Jan 24 2020 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Option Exercise | A | 10.19 | 141,910 | 1,446,063 | 141,910 | |
Jan 24 2020 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Grant | A | 0.00 | 82,070 | 0 | 82,070 | 0 to 82.1 K |
Jul 25 2019 | OBLN | OBALON THERAPEUTIC ... | MOATAZEDI DAVID | Grant | A | 0.00 | 78,125 | 0 | 83,619 | 5.5 K to 83.6 K (+1,422.01 %) |